top of page
NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
55513-0111-01 | J0881 | INJECTION, DARBEPOETIN ALFA, 1 MICROGRAM (NON-ESRD USE) | ARANESP (PF) 0.3 MG/0.6 ML | IJ |
55513-0126-01 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN (S.D.V.,S2,PF) 2000 U/ML | IJ |
55513-0126-10 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN (S.D.V.,S2,PF) 2000 U/ML | IJ |
55513-0132-01 | Q5117 | INJECTION, TRASTUZUMAB-ANNS, BIOSIMILAR, (KANJINTI), 10 MG | KANJINTI (PF,LYOPHILIZED) 420 MG | IV |
55513-0141-01 | Q5117 | INJECTION, TRASTUZUMAB-ANNS, BIOSIMILAR, (KANJINTI), 10 MG | KANJINTI (SDV,PF,LATEX-FREE) 150 MG | IV |
55513-0144-01 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN (S.D.V.,S10,PF) 10000 U/ML | IJ |
55513-0144-10 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN (S.D.V.,S10,PF) 10000 U/ML | IJ |
55513-0148-01 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN (S.D.V.,S4,PF) 4000 U/ML | IJ |
55513-0148-10 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN (S.D.V.,S4,PF) 4000 U/ML | IJ |
55513-0150-01 | J9039 | INJECTION, BLINATUMOMAB, 1 MICROGRAM | BLINCYTO (INNER VIAL NDC,PF) 35 MCG | IV |
55513-0160-01 | J9039 | INJECTION, BLINATUMOMAB, 1 MICROGRAM | BLINCYTO (W/ SOLN STABALIZER,PF) 35 MCG | IV |
55513-0164-01 | Q5117 | INJECTION, TRASTUZUMAB-ANNS, BIOSIMILAR, (KANJINTI), 10 MG | KANJINTI KIT (W/DILUENT,PF) 420 MG | IV |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page